Scandinavian Journal of Urology
Volume 57, 2023 - Issue 1-6
Articles
Onset of androgen deprivation therapy leads to rapid deterioration of body composition, physical performance, cardiometabolic health and quality-of-life in prostate cancer patients
Maarten Overkampa Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research & Development, Utrecht, The Netherlands;b NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands;c TiFN, Wageningen, The Netherlands
https://orcid.org/0000-0003-1363-6414View further author information
https://orcid.org/0000-0003-1363-6414View further author information, Lisanne H. P. Houbena Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research & Development, Utrecht, The Netherlands;b NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands;c TiFN, Wageningen, The Netherlandshttps://orcid.org/0000-0001-8543-282XView further author information
https://orcid.org/0000-0001-8543-282XView further author information, , Joep G. H. van Roermunde Department of Urology, Maastricht University Medical Center+, Maastricht, The Netherlandshttps://orcid.org/0000-0002-6067-7502View further author information
https://orcid.org/0000-0002-6067-7502View further author information, , , Mads S. Larsenh Arla Foods Ingredients Group P/S, Viby J, Denmarkhttps://orcid.org/0000-0001-5936-0375View further author information
https://orcid.org/0000-0001-5936-0375View further author information, Luc J. C. van Loonb NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands;c TiFN, Wageningen, The NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0002-6768-9231View further author information
https://orcid.org/0000-0002-6768-9231View further author information, Milou Beelenb NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands;c TiFN, Wageningen, The Netherlandshttps://orcid.org/0000-0002-0065-1167View further author information
https://orcid.org/0000-0002-0065-1167View further author information & Sandra Beijera Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research & Development, Utrecht, The Netherlands;c TiFN, Wageningen, The Netherlandshttps://orcid.org/0000-0002-2510-8179View further author information
https://orcid.org/0000-0002-2510-8179View further author information show all